Motokazu Kato

Benralizumab for the Prevention of COPD Exacerbations

Gerard J. Criner, Bartolomé R. Celli, Christopher E. Brightling et al. · New England Journal of Medicine · 2019 · 331 citations · Full text

Medicine, Immunology, Pharmacotherapy +14

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

William W. Busse, Eugene R. Bleecker, J Mark FitzGerald et al. · The Lancet Respiratory Medicine · 2018 · 311 citations

Pharmacy, Pharmacology, Pharmacotherapy +6

Long-term Safety and Clinical Benefit of Mepolizumab in Patients With the Most Severe Eosinophilic Asthma: The COSMEX Study

Sandhya Khurana, Guy Brusselle, Elisabeth H. Bel et al. · Clinical Therapeutics · 2019 · 166 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Frequent productive cough: Symptom burden and future exacerbation risk among patients with asthma and/or COPD in the NOVELTY study

Rod Hughes, Eleni Rapsomaniki, Christer Janson et al. · Respiratory Medicine · 2022 · 44 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +15

Efficacy and safety of benralizumab in Japanese patients with severe, uncontrolled eosinophilic asthma

Ken Ohta, Mitsuru Adachi, Yuji Tohda et al. · Allergology International · 2017 · 29 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17